These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2439836)

  • 1. Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
    Bayliss J; Thomas L; Poole-Wilson P
    J Cardiovasc Pharmacol; 1987 May; 9(5):551-4. PubMed ID: 2439836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
    Jaski BE; Peters C
    Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
    Tan LB; Littler WA; Murray RG
    Int J Cardiol; 1991 Feb; 30(2):203-8. PubMed ID: 2010243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock.
    Levy B; Nace L; Bollaert PE; Dousset B; Mallie JP; Larcan A
    Intensive Care Med; 1999 Sep; 25(9):942-8. PubMed ID: 10501749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
    Baumann G; Felix SB; Filcek SA
    Am J Cardiol; 1990 Mar; 65(11):748-54. PubMed ID: 1969223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting.
    MacGregor DA; Butterworth JF; Zaloga CP; Prielipp RC; James R; Royster RL
    Chest; 1994 Sep; 106(3):835-41. PubMed ID: 7915979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure.
    Baumann G; Gutting M; Pfafferott C; Ningel K; Klein G
    Eur Heart J; 1988 May; 9(5):503-12. PubMed ID: 3402466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy of dopexamine and dobutamine for increasing oxygen delivery in high-risk surgical patients.
    Boyd O; Lamb G; Mackay CJ; Grounds RM; Bennett ED
    Anaesth Intensive Care; 1995 Aug; 23(4):478-84. PubMed ID: 7485941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
    Santman FW
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
    Lang RM; Borow KM; Neumann A; Carroll JD; Weinert L; Murphy MB; Ghali J; Rajfer SI
    Am J Cardiol; 1988 Aug; 62(5):46C-52C. PubMed ID: 2841838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of dibutyryl cyclic AMP in patients with congestive heart failure--comparison with dobutamine and captopril.
    Nakanishi M; Yokota Y; Fukuzaki H
    Jpn Circ J; 1988 Jun; 52(6):503-10. PubMed ID: 2845163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
    Svenson G; Strandberg LE; Lindvall B; Erhardt L
    Br Heart J; 1988 Dec; 60(6):489-96. PubMed ID: 3224052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
    Dawson JR; Thompson DS; Signy M; Juul SM; Turnbull P; Jenkins BS; Webb-Peploe MM
    Br Heart J; 1985 Sep; 54(3):313-20. PubMed ID: 4041300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.
    Leier CV; Heban PT; Huss P; Bush CA; Lewis RP
    Circulation; 1978 Sep; 58(3 Pt 1):466-75. PubMed ID: 679437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
    Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U
    Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic comparison of dopexamine and nitroprusside at high and low doses in patients with coronary artery disease and impaired left ventricular function.
    Ikram H; Foy SG; Low CJ; Redfern SA; Shirlaw TM; Bennett SI; Crozier IG
    J Cardiovasc Pharmacol; 1995 Nov; 26(5):777-83. PubMed ID: 8637193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
    Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.